跳至主要内容
临床试验/IRCT20140420017365N4
IRCT20140420017365N4已完成3 期

Evaluation Efficacy of Tranexamic acid in decreasing blood loss in cesarean delivery

Oroumia University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Candidate for Elective Singleton Cesarean section
  • Having adequate prenatal care.
  • Complete the form of informed consent
  • Age range 18-45 years

排除标准

  • Patients do not accept to participate in the study
  • They have anemia and bleeding diseases or serious medical or surgical diseases
  • Sensitivity to Tranexamic acid
  • Fetal macrosomia
  • Thromboembolism Score(V.T.E. scoring)=3
  • Placental Abruption , placenta parvia and abnormal placental adherence
  • Uterine myoma more than 5 cm
  • Polyhydramnios
  • Multi-fetus pregnancy
  • Use of Anticoagulant such as enoxaparin or heparin
  • Severe pregnancy complications such as preeclampsia
  • Long-term hospitalization more than 3 days before cesarean section

研究者

发起方
Oroumia University of Medical Sciences

相似试验